Explore the Global Personalized Medicine Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Personalized Medicine Market

Key Insight

Personalized medicine sales will grow through 2036, with diagnostics remaining central as biomarker testing, genomic profiling, and companion diagnostics guide treatment selection. Therapeutics gain traction as targeted oncology, immunology, and gene-based treatments move deeper into clinical use. The market is expected to reach USD 419.1 billion in 2026 and USD 779.4 billion by 2036.

February 18, 2026

Anurag Sharma

250 Pages

Cite this Report

Personalized Medicine Market

https://www.futuremarketinsights.com/reports/personalized-medicine-market

License

Buy Now

Summary ToC Companies

Key Players

Asuragen Inc
Biogen International
Celera Diagnostics LLC
Dako Inc
Exact Sciences Corporation
Exagen Inc
Genelex Corporation
Precision Biologics Incorporated
Qiagen

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Personalized Medicine Market

Key Players

Similar Industry Reports